177 related articles for article (PubMed ID: 31567163)
1. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.
Kendall EA; Durovni B; Martinson NA; Cavalacante S; Masonoke K; Saraceni V; Lebina L; Efron A; Cohn S; Chon S; Chaisson RE; Dowdy DW; Golub JE;
AIDS; 2020 Jan; 34(1):63-71. PubMed ID: 31567163
[TBL] [Abstract][Full Text] [Related]
2. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.
Durovni B; Saraceni V; Moulton LH; Pacheco AG; Cavalcante SC; King BS; Cohn S; Efron A; Chaisson RE; Golub JE
Lancet Infect Dis; 2013 Oct; 13(10):852-8. PubMed ID: 23954450
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.
Golub JE; Cohn S; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; Durovni B; Chaisson RE
Clin Infect Dis; 2015 Feb; 60(4):639-45. PubMed ID: 25365974
[TBL] [Abstract][Full Text] [Related]
4. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
[TBL] [Abstract][Full Text] [Related]
5. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
[TBL] [Abstract][Full Text] [Related]
6. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ
JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800
[TBL] [Abstract][Full Text] [Related]
7. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
8. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
Chamie G; Hahn JA; Kekibiina A; Emenyonu NI; Beesiga B; Marson K; Fatch R; Lodi S; Adong J; Thirumurthy H; McDonell MG; Gandhi M; Bryant K; Havlir DV; Kamya MR; Muyindike WR
Lancet Glob Health; 2023 Dec; 11(12):e1899-e1910. PubMed ID: 37973340
[TBL] [Abstract][Full Text] [Related]
9. Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules.
le Roux SM; Cotton MF; Golub JE; le Roux DM; Workman L; Zar HJ
BMC Med; 2009 Nov; 7():67. PubMed ID: 19886982
[TBL] [Abstract][Full Text] [Related]
10. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.
Akamike IC; Okedo-Alex IN; Agu AP; Alo C; Ogbonnaya LU
Pan Afr Med J; 2020; 36():261. PubMed ID: 33014257
[TBL] [Abstract][Full Text] [Related]
12. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
14. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
[TBL] [Abstract][Full Text] [Related]
15. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
16. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
Churchyard GJ; Fielding K; Charalambous S; Day JH; Corbett EL; Hayes RJ; Chaisson RE; De Cock KM; Samb B; Grant AD
AIDS; 2003 Sep; 17(14):2063-70. PubMed ID: 14502009
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
[TBL] [Abstract][Full Text] [Related]
19. Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Churchyard G; Cárdenas V; Chihota V; Mngadi K; Sebe M; Brumskine W; Martinson N; Yimer G; Wang SH; Garcia-Basteiro AL; Nguenha D; Masilela L; Waggie Z; van den Hof S; Charalambous S; Cobelens F; Chaisson RE; Grant AD; Fielding KL;
Ann Intern Med; 2021 Oct; 174(10):1367-1376. PubMed ID: 34424730
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
Mosimaneotsile B; Mathoma A; Chengeta B; Nyirenda S; Agizew TB; Tedla Z; Motsamai OI; Kilmarx PH; Wells CD; Samandari T
J Acquir Immune Defic Syndr; 2010 May; 54(1):71-7. PubMed ID: 19934764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
